VIEKIRAX

This brand name is authorized in Austria, Cyprus, Estonia, Finland, Ireland, Lithuania, Poland, Romania, Tunisia, Turkey

Active ingredients

The drug VIEKIRAX contains a combination of these active pharmaceutical ingredients (APIs):

1 Ombitasvir
UNII 2302768XJ8 - OMBITASVIR

Ombitasvir is an nonstructural protein 5A (NS5A) inhibitor that acts by inhibiting the HCV protein NS5A.

Read about Ombitasvir
2 Paritaprevir
UNII OU2YM37K86 - PARITAPREVIR
Read about Paritaprevir
3 Ritonavir
UNII O3J8G9O825 - RITONAVIR

Ritonavir is an orally active peptidomimetic inhibitor of the HIV-1 and HIV-2 aspartyl proteases. Inhibition of HIV protease renders the enzyme incapable of processing the gag-pol polyprotein precursor which leads to the production of HIV particles with immature morphology that are unable to initiate new rounds of infection. Ritonavir has selective affinity for the HIV protease and has little inhibitory activity against human aspartyl proteases. Pharmacokinetic enhancement by ritonavir is based on ritonavir’s activity as a potent inhibitor of CYP3A-mediated metabolism.

Read about Ritonavir

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
VIEKIRAX Film-coated tablet European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
J05AP53 J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AP Antivirals for treatment of HCV infections
Discover more medicines within J05AP53

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EE Ravimiamet Identifier(s): 1674716
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 476808
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1075471
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100334324
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W64675001
Country: TN Direction de la Pharmacie et du Médicament Identifier(s): 15623031H, 16913021H
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8680656080346

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.